홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Octopamine → Dopamine

HRID 1296166
인쇄

반응식

HRID 1296166 반응식
NCCC1C=CC(O)=CC=1.C1C(C(O)CN)=CC=C(O)C=1.[CH:22]1[C:27]([C@@H:28](O)[CH2:29][NH2:30])=[CH:26][C:25]([OH:32])=[C:24]([OH:33])[CH:23]=1>>[NH2:30][CH2:29][CH2:28][C:27]1[CH:22]=[CH:23][C:24]([OH:33])=[C:25]([OH:32])[CH:26]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 4581Octopamine4회HCID 5610Tyramine4회HCID 439260Norepinephrine4회

생성물 1

HCID 681Dopamine

실험 절차

Tyramine (TA), octopamine (OA) and norepinephrine (NE), naturally occurring monoamines that have a similar structure to DA, were tested together with DA for their ability to inhibit 3H-DA uptake. The concentration range of an unlabeled competitive inhibitor was selected according to the expected IC50 value. The IC50 values obtained were 0.39±0.11 μM for TA, 1.92±0.28 μM for OA, 4.10±1.02 μM for DA and 22.04±2.94 μM for NE. The apparent Ki values (calculation based on Cheng et al., (1973) Biochem Pharmacol 22:3099) were 0.35±0.10 μM for TA, 1.74±0.25 μM for OA, 3.72±0.92 μM for DA and 20.04±2.67 μM for NE. The rank order of apparent Ki on OA/TAT for potential substrates was: TA<OA<DA<NE.

후처리

  1. customThe IC50 values obtained

출처 및 근거

ORD 기록
ord-9ea291c5b4284adb9f35c7841543ca32
출처 데이터셋
uspto-grants-2007_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07244837B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트